Citations

Mayo Clinic

Showing 10 of 108522 citations.

Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma
Nanda, Arjun , Berger, Stephen, Lewis, Melinda M., Keilin, Steven , Woods, Kevin E. , Cai, Qiang , Willingham, Field F. , Barr Fritcher, Emily G, Brown, Jason , Fritcher, Emily G. Barr , Gores, Gregory J. , Willingham, Field F

Therapeutic Advances in Gastroenterology | January 7, 2015 | Volume: 8 | Issue: 2 | Pages: 56-65

10.1177/1756283x14564674 | PMID 25729431 Get It

Objectives: Brush cytology has a low sensitivity for the diagnosis of cholangiocarcinoma. This study aimed to compare the standard approach (brush cytology) with a triple modality approach utilizing brush cytology, forceps biopsy and fluorescence in situ hybridization in terms of sensitivity and specificity for the diagnosis of cholangiocarcinoma. Methods: In a retrospective study at a single academic center, 50 patients underwent triple modality testing. Additionally, 61 patients underwent brush cytology alone. Intervention was endoscopic retrograde cholangiopancreatography with brush cytology, fluorescence in situ hybridization, and forceps biopsy. The main outcome measures included sensitivity, specificity, positive predictive value and negative predictive value. Results: Overall, 50 patients underwent triple tissue sampling, and 61 patients underwent brush cytology alone. Twenty-two patients were eventually diagnosed with cholangiocarcinoma. Brush cytology had a sensitivity of 42%, specificity of 100%, positive predictive value of 100% and negative predictive value of 88%. Triple tissue sampling had an overall sensitivity of 82%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 87%. Within the triple test group, brush cytology had a sensitivity of 27%, forceps biopsy had a sensitivity of 50%, and fluorescence in situ hybridization analysis had a sensitivity of 59%. Conclusions: A triple modality approach results in a marked increase in sensitivity for the diagnosis of cholangiocarcinoma compared with single modality testing such as brush cytology and should be considered in the evaluation of indeterminate or suspicious biliary strictures.
The Full Spectrum of Hepatic Steatosis in Children
Hourigan, Suchitra K. , Tibesar, Eric , Scheimann, Ann , Torbenson, Michael

Clinical Pediatrics | January 7, 2015 | Volume: 54 | Issue: 7 | Pages: 635-642

10.1177/0009922814566927 | PMID 25567295 Get It

Objective: We aim to identify the spectrum of etiologies of steatosis in pediatric liver biopsies. Methods: Information was collected from 155 children with steatosis on liver biopsy, including anthropometrics, laboratory, and radiologic data. Biopsies were reviewed by a liver pathologist. Results: The 4 major diagnoses associated with hepatic steatosis were nonalcoholic fatty liver disease (37%), metabolic disease (9%), oncologic disease (8%) and viral hepatitis (7%). Patients with nonalcoholic fatty liver disease were older ( P = .0001) and more likely to have a body mass index z score >2 ( P < .0001). Patients with a metabolic diagnosis were younger ( P = .0002). Radiologic imaging of the liver yielded normal results in 44 of 108 of children (30%); 7 of these had >66% macrovesicular fatty change on biopsy, and 3 had severe fibrosis/cirrhosis. Conclusions: The range of causes of steatosis in pediatric liver biopsies is broad. Not all patients, even with advanced liver disease, had abnormalities with liver imaging, emphasizing the role for liver biopsy in certain cases.
IL‐33 facilitates oncogene‐induced cholangiocarcinoma in mice by an interleukin‐6‐sensitive mechanism
Razumilava, Nataliya , Bronk, Steven F., Davila, Jaime , Champion, Mia D., Bezerra, Jorge A. , Chen, Xin , Yamada, Daisaku, Yamada, Daisaku , Ilyas, Sumera I. , Borad, Mitesh J. , Gores, Gregory J. , Davila, Jaime I

Hepatology | January 7, 2015 | Volume: 61 | Issue: 5 | Pages: 1627-1642

10.1002/hep.27687 | PMID 25580681 Get It

Cholangiocarcinoma (CCA) is a lethal hepatobiliary neoplasm originating from the biliary apparatus. In humans, CCA risk factors include hepatobiliary inflammation and fibrosis. The recently identified interleukin (IL)−1 family member, IL‐33, has been shown to be a biliary mitogen which also promotes liver inflammation and fibrosis. Our aim was to generate a mouse model of CCA mimicking the human disease. Ectopic oncogene expression in the biliary tract was accomplished by the Sleeping Beauty transposon transfection system with transduction of constitutively active AKT (myr‐AKT) and Yes‐associated protein. Intrabiliary instillation of the transposon–transposase complex was coupled with lobar bile duct ligation in C57BL/6 mice, followed by administration of IL‐33 for 3 consecutive days. Tumors developed in 72% of the male mice receiving both oncogenes plus IL‐33 by 10 weeks but in only 20% of the male mice transduced with the oncogenes alone. Tumors expressed SOX9 and pancytokeratin (features of CCA) but were negative for HepPar1 (a marker of hepatocellular carcinoma). Substantive overlap with human CCA specimens was revealed by RNA profiling. Not only did IL‐33 induce IL‐6 expression by human cholangiocytes but it likely facilitated tumor development in vivo by an IL‐6–sensitive process as tumor development was significantly attenuated in Il‐6–/– male animals. Furthermore, tumor formation occurred at a similar rate when IL‐6 was substituted for IL‐33 in this model. Conclusion: The transposase‐mediated transduction of constitutively active AKT and Yes‐associated protein in the biliary epithelium coupled with lobar obstruction and IL‐33 administration results in the development of CCA with morphological and biochemical features of the human disease; this model highlights the role of inflammatory cytokines in CCA oncogenesis. (Hepatology 2015;61:1627–1642)
Cardiovascular Risk Profile at the Onset of Psoriatic Arthritis: A Population‐Based Cohort Study
Ernste, Floranne C. , Sánchez-Menéndez, Marta María, Wilton, Katelynn M. , Crowson, Cynthia S. , Matteson, Eric L. , Kremers, Hilal Maradit , Maradit Kremers, Hilal

Arthritis Care & Research | January 7, 2015 | Volume: 67 | Issue: 7 | Pages: 1015-1021

10.1002/acr.22536 | PMID 25581120 Get It

ObjectiveThe role of cardiovascular disease (CVD) risk factors in psoriatic arthritis (PsA) is poorly understood. We examined the prevalence of CVD risk factors at initial onset of PsA and compared the observed incidence of CVD events with that predicted by the Framingham Risk Score (FRS) to determine its applicability in this patient population.MethodsA population‐based incidence cohort of 158 patients with PsA who fulfilled Classification of Psoriatic Arthritis criteria for PsA in 1989–2008 was assembled. Medical records were reviewed to ascertain CVD risk factors and CVD events. Future risk of CVD was estimated using the FRS algorithm.ResultsMean age was 43.4 years (range 19–74 years), 61% were men, and 44% were obese (body mass index ≥30 kg/m2). Fifty‐four patients (34%) presented with ≥2 CVD risk factors at PsA incidence. Among 126 patients ages ≥30 years at PsA incidence with no prior history of CVD, 33% had an FRS ≥10%, with 11% having an FRS ≥20%, and 18 experienced a CVD event in the first 10 years of disease duration. The 10‐year cumulative incidence of CVD events was 17% (95% confidence interval [95% CI] 10%–24%), almost twice as high as the predicted incidence based on the FRS (standardized incidence ratio 1.80, 95% CI 1.14–2.86; P = 0.012).ConclusionThe majority of newly diagnosed PsA patients have a >10% risk of CVD within 10 years of PsA incidence. The CVD risk in these patients is higher than expected and underestimated by the FRS.
Vascular Imaging Abnormalities and Cognition
Griswold, Michael , Lirette, Seth T. , Kantarci, Kejal , Sharrett, A. Richey , Graff‐Radford, Jonathan , Schneider, Andrea L.C. , Windham, B. Gwen , Coker, Laura H., Albert, Marilyn , Wruck, Lisa , Knopman, David S. , Gottesman, Rebecca F. , Jack, Clifford R. , Mosley, Thomas H. , Kantarci, Kejal , Lirette, Seth , Schneider, Andrea L C , Wruck, Lisa M

Stroke | January 7, 2015 | Volume: 46 | Issue: 2 | Pages: 433-440

10.1161/strokeaha.114.007847 | PMID 25563642 Get It

Background and Purpose— The relationships between cerebrovascular lesions visible on imaging and cognition are complex. We explored the possibility that the cerebral cortical volume mediated these relationships. Methods— Total of 1906 nondemented participants (59% women; 25% African–American; mean age, 76.6 years) in the Atherosclerosis Risk in Communities (ARIC) study underwent cognitive assessments, risk factor assessments, and quantitative MRI for white matter hyperintensities (WMH) and infarcts. The Freesurfer imaging analysis pipeline was used to determine regional cerebral volumes. We examined the associations of cognitive domain outcomes with cerebral volumes (hippocampus and separate groups of posterior and frontal cortical regions of interest) and cerebrovascular imaging features (presence of large or small cortical/subcortical infarcts and WMH volume). We performed mediation pathway analyses to assess the hypothesis that hippocampal and cortical volumes mediated the associations between cerebrovascular imaging features and cognition. Results— In unmediated analyses, WMH and infarcts were both associated with worse psychomotor speed/executive function. In mediation analyses, WMH and infarct associations on psychomotor speed/executive function were significantly attenuated, but not abolished, by the inclusion of the posterior cortical regions of interest volume in the models, and the infarcts on psychomotor speed/executive function association were attenuated, but not abolished, by inclusion of the frontal cortical regions of interest volume. Conclusions— Both WMH and infarcts were associated with cortical volume, and both lesions were also associated with cognitive performance, implying shared pathophysiological mechanisms. Although cross-sectional, our findings suggest that WMH and infarcts could be proxies for clinically covert processes that directly damage cortical regions. Microinfarcts are 1 candidate for such a clinically covert process.
Metastatic renal cell carcinoma mimicking diverticulitis in a patient with chronic lymphocytic leukaemia
Hwang, Soyun M., Kuyava, J M, Grande, JP, Swetz, Keith M.

BMJ Case Reports | January 7, 2015 | Volume: 2015 | Issue: No issue available | Pages: bcr2014206101

10.1136/bcr-2014-206101 | PMID 25568267 Get It

We present an unusual case of metastatic renal cell carcinoma (RCC) mimicking diverticulitis in a 76-year-old man with a 16-year history of chronic lymphocytic leukaemia (CLL) and a 2 cm left renal mass. The patient presented with severe abdominal pain and lower gastrointestinal bleeding with anticoagulation from recent pulmonary embolism. His clinical course was troubled by recurrent hospitalisations and complications that delayed investigations and potential treatments. Radiographic findings revealed stable CLL, mild sigmoid diverticulitis and a small renal mass. Small renal masses (less than 4 cm) are considered low risk for metastasising and are, thus, often observed or ablated, rather than resected. Furthermore, gastrointestinal metastases from RCC are rare. This case adds new perspective to the unpredictable nature of RCC and how synchronous malignancies may be masked in patients with long-standing CLL.
Ketamine for Posttraumatic Stress Disorder
Rasmussen, Keith G.

JAMA Psychiatry | January 7, 2015 | Volume: 72 | Issue: 1 | Pages: 94

10.1001/jamapsychiatry.2014.1621 | PMID 25564790 Get It

Factors Influencing Treatment Adherence and Discontinuation in Women with Breast Cancer
Ruddy, Kathryn J. , Kasi, Pashtoon Murtaza

Breast Cancer Management | January 7, 2015 | Volume: 4 | Issue: 1 | Pages: 25-31

10.2217/bmt.14.48 Get It

Infections After Breast Surgery: Potential Ways to Reduce Infection Rates
Throckmorton, Alyssa , Degnim, Amy C.

Breast Cancer Management | January 7, 2015 | Volume: 4 | Issue: 1 | Pages: 17-24

10.2217/bmt.14.46 Get It

Findings of a Naloxone Database and its Utilization to Improve Safety and Education in a Tertiary Care Medical Center
Rosenfeld, David M. , Betcher, Jeffrey, Shah, Ruby A., Cheng, Meng‐Ru, Cubillo, Efrain I., Griffin, Julia, Trentman, Terrence L. , Betcher, Jeffrey A, Chang, Yu‐Hui H., Griffin, Julia M, Chang, Yu‐Hui

Pain Practice | January 7, 2015 | Volume: 16 | Issue: 3 | Pages: 327-333

10.1111/papr.12277 | PMID 25564757 Get It

AbstractIntroductionAnalyzing hospital naloxone use may assist in identification of areas for quality and safety improvement. Our primary objective is to quantitate the incidence of hospital naloxone use and to assess certain patient populations at risk.MethodsDuring the years 2008 to 2011, each clinical scenario where naloxone was administered on an in‐patient care ward was reviewed. The events were assessed to separate situations where naloxone rescue was effective in reversing opioid‐induced intoxication vs. others. Further analysis was conducted to stratify patient populations at greatest risk.ResultsNaloxone was administered for well‐defined opioid‐induced respiratory depression and oversedation 61% of the time, the remainder used for patient deterioration of other etiology. Surgical populations are at risk with an incidence of 3.8/1,000 hospitalized patients, and this is the greatest within 24 hours of surgery. General surgical patients represent the highest surgical patient risk at 5.5/1,000. Medical patients represent lower risk at 2.0/1,000. Patients with patient‐controlled analgesia and epidural opioid infusion are high risk at 12.1 and 13.1/1,000 patients, respectively. Many quality and safety interventions were gradually implemented in response to this data and are summarized. These include nursing and provider education, electronic medical record modification, and more stringent patient monitoring practices.ConclusionExamination of naloxone use can assist in the identification and stratification of patients at risk for opioid‐induced respiratory depression and oversedation and can serve as a driver for improvements in hospital patient safety. This information can also guide other institutions interested in similar improvements.